Post-conization pathological upgrading and outcomes of 466 patients with low-grade cervical intraepithelial neoplasia
Frontiers in Oncology · 11.09.2024 · 14
DOI: 10.3389/fonc.2024.1449080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 11.09.2024. Verfasst von Yulin Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cervical Cancer Control Center of Hubei Province, Maternal and Child Health Hospital of Hubei Province, Wuhan, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The management of patients with low-grade cervical intraepithelial neoplasia (CIN1) remains controversial. We analyzed the pathological upgrading rates of patients with CIN1 undergoing conization, identifying influencing factors, and compared their outcomes to those of patients with CIN1 receiving follow-up only.
Methods
This retrospective study included 466 patients with CIN1 confirmed by histopathology and treated with conization. Postoperative pathological upgrading was determined and its influencing factors were identified. We also analyzed post-conization outcomes, examining the rate of persistent/recurrent CIN1 and its influencing factors, and comparing these results to those of patients receiving follow-up only.
Results
The pathological upgrading rate of patients with CIN1 after conization was 21.03% (98/466), and the influencing factors were preoperative high-risk human papillomavirus (HR-HPV) infection and cytological results. The upgrading rates of HR-HPV positive and negative patients were 22.05% and 0.00%, respectively ( χ 2 = 5.03, P =0.03). The upgrading rate of patients with cytological results negative for intraepithelial lesion malignancy was 10.94%, while the upgrading rates of atypical squamous cells, cannot exclude high-grade lesion(ASC-H) and high-grade squamous intraepithelial lesion(HSIL) groups were 47.37% and 52.94%, respectively ( χ 2 = 22.7, P =0.03). Persistent/recurrent CIN1 rates in the conization group were 21.24%, 15.97%, and 6.67% at 6, 12, and 24 months, respectively, significantly lower than those in the follow-up only group. The CIN2 progression rate in the conization group (0.26%) during the 24-month follow-up period was also significantly lower than that in the follow-up only group (15.15%; χ 2 = 51.68, P <0.01). The only factor influencing postoperative persistent/recurrent CIN1 was preoperative HR-HPV status. No patients who were HR-HPV negative preoperatively exhibited persistent/recurrent CIN1, compared with 25.55% of those who were HR-HPV positive preoperatively ( χ 2 = 4.40, P =0.04).
Discussion
The risk of progression to CIN2+ in the medium term is higher in patients with CIN1 receiving follow-up than in those undergoing conization. Doctors should refer to the guidelines but comprehensively consider age, fertility requirements, preoperative HR-HPV and cytological results, follow-up conditions, and other factors to select the most appropriate treatment strategy for patients with CIN1.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cervical Cancer Control Center of Hubei Province, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.
- Hubei Clinical Medical Research Center for Gynecologic Malignancy, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.
Zitieren
APA
Guo, Y., Cai, H., Peng, Q., Wang, Y., Li, L., Zou, M., Guo, J., Wang, C., Wu, X., & Ma, Q. (2024). Post-conization pathological upgrading and outcomes of 466 patients with low-grade cervical intraepithelial neoplasia. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1449080
Vancouver
Guo Y, Cai H, Peng Q, Wang Y, Li L, Zou M, et al. Post-conization pathological upgrading and outcomes of 466 patients with low-grade cervical intraepithelial neoplasia. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1449080
BibTeX
@article{Guo2024,
author = {Guo, Yulin and Cai, Hongning and Peng, Qiuzi and Wang, Ying and Li, Lu and Zou, Miao and Guo, Jinyue and Wang, Chaonan and Wu, Xufeng and Ma, Quanfu},
title = {Post-conization pathological upgrading and outcomes of 466 patients with low-grade cervical intraepithelial neoplasia},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1449080}
}
EUVIMED